Stock Analysis on Net

Baxter International Inc. (NYSE:BAX)

This company has been moved to the archive! The financial data has not been updated since August 4, 2016.

Analysis of Long-term (Investment) Activity Ratios

Microsoft Excel

Long-term Activity Ratios (Summary)

Baxter International Inc., long-term (investment) activity ratios

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Net fixed asset turnover 2.27 1.92 1.95 2.33 2.51
Total asset turnover 0.48 0.64 0.59 0.70 0.73
Equity turnover 1.13 2.05 1.80 2.05 2.11

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

Long-term activity ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. Baxter International Inc. net fixed asset turnover ratio deteriorated from 2013 to 2014 but then improved from 2014 to 2015 exceeding 2013 level.
Total asset turnover An activity ratio calculated as total revenue divided by total assets. Baxter International Inc. total asset turnover ratio improved from 2013 to 2014 but then deteriorated significantly from 2014 to 2015.
Equity turnover An activity ratio calculated as total revenue divided by shareholders’ equity. Baxter International Inc. equity turnover ratio improved from 2013 to 2014 but then deteriorated significantly from 2014 to 2015.

Net Fixed Asset Turnover

Baxter International Inc., net fixed asset turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Selected Financial Data (US$ in millions)
Net sales 9,968 16,671 15,259 14,190 13,893
Property, plant and equipment, net 4,386 8,698 7,832 6,098 5,525
Long-term Activity Ratio
Net fixed asset turnover1 2.27 1.92 1.95 2.33 2.51
Benchmarks
Net Fixed Asset Turnover, Competitors2
Abbott Laboratories
Cigna Group
CVS Health Corp.
Danaher Corp.
Elevance Health Inc.
Humana Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

1 2015 Calculation
Net fixed asset turnover = Net sales ÷ Property, plant and equipment, net
= 9,968 ÷ 4,386 = 2.27

2 Click competitor name to see calculations.

Long-term activity ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. Baxter International Inc. net fixed asset turnover ratio deteriorated from 2013 to 2014 but then improved from 2014 to 2015 exceeding 2013 level.

Total Asset Turnover

Baxter International Inc., total asset turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Selected Financial Data (US$ in millions)
Net sales 9,968 16,671 15,259 14,190 13,893
Total assets 20,975 25,917 25,869 20,390 19,073
Long-term Activity Ratio
Total asset turnover1 0.48 0.64 0.59 0.70 0.73
Benchmarks
Total Asset Turnover, Competitors2
Abbott Laboratories
Cigna Group
CVS Health Corp.
Danaher Corp.
Elevance Health Inc.
Humana Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

1 2015 Calculation
Total asset turnover = Net sales ÷ Total assets
= 9,968 ÷ 20,975 = 0.48

2 Click competitor name to see calculations.

Long-term activity ratio Description The company
Total asset turnover An activity ratio calculated as total revenue divided by total assets. Baxter International Inc. total asset turnover ratio improved from 2013 to 2014 but then deteriorated significantly from 2014 to 2015.

Equity Turnover

Baxter International Inc., equity turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Selected Financial Data (US$ in millions)
Net sales 9,968 16,671 15,259 14,190 13,893
Total Baxter shareholders’ equity 8,846 8,120 8,463 6,938 6,585
Long-term Activity Ratio
Equity turnover1 1.13 2.05 1.80 2.05 2.11
Benchmarks
Equity Turnover, Competitors2
Abbott Laboratories
Cigna Group
CVS Health Corp.
Danaher Corp.
Elevance Health Inc.
Humana Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

1 2015 Calculation
Equity turnover = Net sales ÷ Total Baxter shareholders’ equity
= 9,968 ÷ 8,846 = 1.13

2 Click competitor name to see calculations.

Long-term activity ratio Description The company
Equity turnover An activity ratio calculated as total revenue divided by shareholders’ equity. Baxter International Inc. equity turnover ratio improved from 2013 to 2014 but then deteriorated significantly from 2014 to 2015.